Adherence, placebo effects, and mortality

Journal of General Internal Medicine

Volumn 25, Issue 12, 2010, Pages 1270-1272

  Wilson, Ira B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

adherent patients; mortality; placebo

Indexed keywords

PLACEBO;

ARTICLE; EXPECTATION; HEART LEFT VENTRICLE FAILURE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE;

HUMANS; MORTALITY; PATIENT COMPLIANCE; PLACEBO EFFECT;

EID: 78649939210     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1530-7     Document Type: Article

References (24)

1. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303:1038-1041.
2. Clofibrate and niacin in coronary heart disease. JAMA. 1975;231:360-381.
3. RI Horwitz CM Viscoli L Berkman, et al. 1990 Treatment adherence and risk of death after a myocardial infarction [see comments] Lancet 336 542 545 1:STN:280:DyaK3czlsFOhtQ%3D%3D 10.1016/0140-6736(90)92095-Y 1975045 (Pubitemid 20278106)
4. EJ Gallagher CM Viscoli RI Horwitz 1993 The relationship of treatment adherence to the risk of death after myocardial infarction in women JAMA 270 742 744 1:STN:280:DyaK3szivFOmug%3D%3D 10.1001/jama.270.6.742 8336377 (Pubitemid 23226634)
5. RJ Glynn JE Buring JE Manson F LaMotte CH Hennekens 1994 Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study Arch Intern Med 154 2649 2657 1:STN:280:DyaK2M%2FosFelsg%3D%3D 7993148
6. Feinstein AR. Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia: W.B. Saunders; 1985.
7. BB Granger K Swedberg I Ekman, et al. 2005 Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial Lancet 366 2005 2011 1:CAS:528:DC%2BD2MXht12ku7nP 10.1016/S0140-6736(05)67760-4 16338449 (Pubitemid 41773375)
8. Avins AL, Pressman A, Ackerson L, Rudd P, Neuhaus J, Vittinghoff E. Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction. J Gen Intern Med. 2010. doi: 10.1007/s11606-010-1477-8
9. SH Simpson DT Eurich SR Majumdar, et al. 2006 A meta-analysis of the association between adherence to drug therapy and mortality BMJ 333 15 10.1136/bmj.38875.675486.55 16790458
10. IB Wilson WH Rogers H Chang DG Safran 2005 Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study J Gen Intern Med 20 715 720 10.1111/j.1525-1497.2005.0128.x 16050880 (Pubitemid 41149107)
11. MR DiMatteo HS Lepper TW Croghan 2000 Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med 160 2101 2107 1:STN:280:DC%2BD3czptVKgug%3D%3D 10.1001/archinte.160.14.2101 10904452
12. Czajkowski SM, Chesney M. Adherence and the Placebo Effect. In: Shumaker SA, Schron EB, Ockene JK, eds. The Handbook of Health Behavior Change. New York: Springer Publishing Company; 1990:409-423.
13. DD Price DG Finniss F Benedetti 2008 A comprehensive review of the placebo effect: recent advances and current thought Annu Rev Psychol 59 565 590 10.1146/annurev.psych.59.113006.095941 17550344
14. A Pollo F Benedetti 2009 The placebo response: neurobiological and clinical issues of neurological relevance Prog Brain Res 175 283 294 10.1016/S0079-6123(09)17520-9 19660663
15. DG Finniss TJ Kaptchuk F Miller F Benedetti 2010 Biological, clinical, and ethical advances of placebo effects Lancet 375 686 695 10.1016/S0140- 6736(09)61706-2 20171404
16. J Schneider SH Kaplan S Greenfield W Li IB Wilson 2004 Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection J Gen Intern Med 19 1096 1103 10.1111/j.1525-1497.2004.30418.x 15566438 (Pubitemid 39552579)
17. MC Beach J Keruly RD Moore 2006 Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med 21 661 665 10.1111/j.1525-1497.2006.00399.x 16808754 (Pubitemid 43801500)
18. JM Kelley AJ Lembo JS Ablon, et al. 2009 Patient and practitioner influences on the placebo effect in irritable bowel syndrome Psychosom Med 71 789 797 10.1097/PSY.0b013e3181acee12 19661195
19. D Mechanic 2004 In my chosen doctor I trust BMJ 329 1418 1419 10.1136/bmj.329.7480.1418 15604163
20. A Bandura 1977 Self-efficacy: toward a unifying theory of behavioral change Psychol Rev 84 191 215 1:STN:280:DyaE2s7kvFCisQ%3D%3D 10.1037/0033-295X.84.2.191 847061
21. KR Lorig P Ritter AL Stewart, et al. 2001 Chronic disease self-management program: 2-year health status and health care utilization outcomes Med Care 39 1217 1223 1:STN:280:DC%2BD3Mnmt1alsw%3D%3D 10.1097/00005650-200111000-00008 11606875 (Pubitemid 33603666)
22. JH Hibbard J Greene M Tusler 2009 Improving the outcomes of disease management by tailoring care to the patient's level of activation Am J Manag Care 15 353 360 19514801
23. MR DiMatteo 2004 Social support and patient adherence to medical treatment: a meta-analysis Health Psychol 23 207 218 10.1037/0278-6133.23.2.207 15008666 (Pubitemid 38365280)
24. JM Simoni PA Frick B Huang 2006 A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy Health Psychol 25 74 81 10.1037/0278-6133.25.1.74 16448300 (Pubitemid 43214384)